Marco L. Davila, MD, PhD, of Roswell Park Comprehensive Cancer Center, will present, “Mechanisms of Toxicity and Treatment Resistance to CD19- targeted CART cells” at Duke Cancer Institutes’ Seminar Series on Wednesday, January 22, 2025, at 8AM. Each seminar is hosted by a Duke Cancer Institute Research Program and features a distinguished scientific leader in their field.
Davila completed his MD and PhD in Immunology at Duke University in 2004. He is currently senior vice president and associate director of translational research and a senior member of the Departments of Medicine and Immunology at Roswell Park Comprehensive Cancer Center in Buffalo, New York.